Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A.
Zahavi T, et al.
NPJ Breast Cancer. 2021 May 28;7(1):67. doi: 10.1038/s41523-021-00277-x.
NPJ Breast Cancer. 2021.
PMID: 34050190
Free PMC article.